While catheter ablation has been proven more effective at stopping atrial fibrillation than antiarrhythmic drugs, pulmonary veins may reconnect and atrial fibrillation may return, causing the catheter ablation to fail. At the recent Heart Rhythm Society meeting, Dr. Vivek Reddy, Director of Cardiac Arrhythmia Services at Mt. Sinai Hospital in New York City, presented clinical …
Read More
A study presented at the recent American College of Cardiology Scientific Sessions by Dr. Matthew Reynolds of the Harvard Clinical Research Institute showed that having a radiofrequency (RF) catheter ablation for atrial fibrillation could reduce the risk of stroke by 40% compared to those who did not have an ablation. To learn more, see: Radiofrequency …
Read More
In this video, Dr. Matthew Reynolds, of the Harvard Clinical Research Institute, discussed his quality of life findings from use of catheter ablation and antiarrhythmic drugs for treatment of atrial fibrillation. He analyzed quality of life data that was collected as part of the THERMOCOOL catheter trial in which catheter ablation was found to be …
Read More
In this video, Dr. Douglas L. Packer of the Mayo Clinic provides details about the landmark CABANA Trial comparing Catheter Ablation to Antiarrhythmic Drugs for Atrial Fibrillation. Dr. Packer is the Lead Investigator for the CABANA Trial. Watch the video, and learn more, at: Dr. Douglas L. Packer on the CABANA Trial comparing Catheter Ablation to …
Read More
New research from Dr. Andrea Natale and colleagues on gender disparities in atrial fibrillation points out that women with afib are less likely to have catheter ablation treatment than men. When they do have atrial fibrillation catheter ablations, they tend to be older and sicker, meaning that they are more likely to have persistent or …
Read More
Important new research from the STOP AF Study of people with paroxysmal atrial fibrillation (AF) shows a type of catheter ablation called cryoablation worked better than drugs to control arrhythmias. One year after treatment, 69.9% of people treated with cryoablation had no episodes of afib compared to 7.3% of those who were treated with anti-arrhythmic …
Read More
At the recent Boston Atrial Fibrillation Symposium, catheter ablation was presented as possibly a better atrial fibrillation (AF) treatment option for serious and professional athletes than antiarrhythmic drugs (AADs). According to Dr. Riccardo Cappato (Institute Policlinics San Donato, Milan, Italy), antiarrhythmic drug therapy has not been popular with this patient population."Even when effective, AADs significantly …
Read More
At Boston Atrial Fibrillation Symposium 2010, Prof. John Camm talked about the two newest antiarrhythmic drugs for atrial fibrillation treatment, dronedarone (Multaq®) and vernakalant. These antiarrhythmic (rhythm control) drugs help to put patients back into normal sinus rhythm, or to keep them in it. See the video: Interview with Professor John Camm at Boston Atrial …
Read More
UPDATED 6-30-09: Study is now complete. An afib research study is looking for afib patients who are near San Francisco, Cincinnati, or New Jersey/New York and who have taken certain anti-arrhythmic medications (Flecainide, Rythmol, Propafenone, and similar). They are offering an honorarium for your time. Find out if you qualify at: Atrial Fibrillation Research Study …
Read More